QIANHAI HEALTH (00911) has released its interim results for the 2026 financial year, reporting a net profit of HK$2.844 million, a decrease of 40.43% compared to the same period last year.

Revenue for the period totaled HK$117 million, down 65.74% year-on-year. Earnings per share stood at 1.68 HK cents.

The company stated that over 98% of its total revenue during the interim period continued to come from its electronic components business. The decline in revenue and gross profit was primarily attributed to supply constraints, upstream quota restrictions, extended channel delivery times, and lower trading volumes.